BMY vs. T
Compare and contrast key facts about Bristol-Myers Squibb Company (BMY) and AT&T Inc. (T).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BMY or T.
Performance
BMY vs. T - Performance Comparison
Returns By Period
In the year-to-date period, BMY achieves a 15.11% return, which is significantly lower than T's 43.52% return. Over the past 10 years, BMY has underperformed T with an annualized return of 2.74%, while T has yielded a comparatively higher 4.37% annualized return.
BMY
15.11%
5.64%
31.08%
16.17%
3.51%
2.74%
T
43.52%
4.47%
33.99%
51.65%
1.09%
4.37%
Fundamentals
| BMY | T | |
|---|---|---|
| Market Cap | $121.33B | $160.08B |
| EPS | -$3.53 | $1.22 |
| PEG Ratio | 2.20 | 1.93 |
| Total Revenue (TTM) | $47.44B | $122.06B |
| Gross Profit (TTM) | $33.40B | $73.12B |
| EBITDA (TTM) | $18.32B | $41.37B |
Key characteristics
| BMY | T | |
|---|---|---|
| Sharpe Ratio | 0.51 | 2.68 |
| Sortino Ratio | 1.01 | 3.70 |
| Omega Ratio | 1.12 | 1.46 |
| Calmar Ratio | 0.30 | 1.72 |
| Martin Ratio | 1.26 | 15.53 |
| Ulcer Index | 11.52% | 3.40% |
| Daily Std Dev | 28.61% | 19.72% |
| Max Drawdown | -70.62% | -64.66% |
| Current Drawdown | -24.61% | 0.00% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between BMY and T is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
BMY vs. T - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and AT&T Inc. (T). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BMY vs. T - Dividend Comparison
BMY's dividend yield for the trailing twelve months is around 4.27%, less than T's 4.89% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.27% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
T AT&T Inc. | 4.89% | 6.62% | 6.66% | 8.45% | 7.23% | 5.22% | 7.01% | 5.04% | 4.51% | 5.46% | 5.48% | 5.12% |
Drawdowns
BMY vs. T - Drawdown Comparison
The maximum BMY drawdown since its inception was -70.62%, which is greater than T's maximum drawdown of -64.66%. Use the drawdown chart below to compare losses from any high point for BMY and T. For additional features, visit the drawdowns tool.
Volatility
BMY vs. T - Volatility Comparison
Bristol-Myers Squibb Company (BMY) has a higher volatility of 13.64% compared to AT&T Inc. (T) at 7.06%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than T based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BMY vs. T - Financials Comparison
This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and AT&T Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities